Quick Answer
Aspire Biopharma Holdings, Inc. reported Total Assets of $1.31 million for fiscal year 2025.
Aspire Biopharma Holdings, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.31M | +786.7% |
| 2024 | $148.0K | -99.3% |
| 2023 | $19.98M | -93.3% |
| 2022 | $300.18M | +102274.0% |
| 2021 | $293.2K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.40M | -63.9% | +142.9% |
| June 30, 2025 | $989.4K | -85.6% | -49.7% |
| March 31, 2025 | $1.97M | -90.3% | +1228.1% |
| December 31, 2024 | $148.0K | -99.3% | -97.8% |
| September 30, 2024 | $6.66M | -66.5% | -3.0% |
| June 30, 2024 | $6.87M | -66.6% | -66.0% |
| March 31, 2024 | $20.20M | -93.3% | +1.1% |
| December 31, 2023 | $19.98M | -93.3% | +0.4% |
- Aspire Biopharma Holdings, Inc. showed an increase of +786.7% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, Aspire Biopharma Holdings, Inc.’s total assets has grown by 347.5% (from $293.2 thousand to $1.31 million).
- The most recent figure is from Aspire Biopharma Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: